Alcon (ALC) Stock Forecast & Price Target

$91.98

-1.29 (-1.38%)

(As of 10/31/2024 ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 15 Analyst Ratings

Sell
0

Hold
2

Buy
13

Based on 15 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a hold rating, and 13 have given a buy rating for ALC.

Consensus Price Target

$101.05
9.86% Upside

According to the 15 analysts' twelve-month price targets for Alcon, the average price target is $101.05. The highest price target for ALC is $110.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 9.86% from the current price of $91.98.

Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

ALC Analyst Ratings Over Time

Type	Current Forecast 11/1/23 to 10/31/24	1 Month Ago 10/2/23 to 10/1/24	3 Months Ago 8/3/23 to 8/2/24	1 Year Ago 11/1/22 to 11/1/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	13 Buy rating(s)	13 Buy rating(s)	7 Buy rating(s)
Hold	2 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$101.05	$99.74	$96.71	$88.81
Forecasted Upside	9.86% Upside	0.62% Upside	4.68% Upside	22.80% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

$5k to $1.3m in just 3 trades (Ad)

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alcon Stock vs. The Competition

Type	Alcon	Medical Companies	S&P 500
Consensus Rating Score	2.87	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	9.11% Upside	15,734.38% Upside	9.97% Upside
News Sentiment Rating	Neutral News See Recent ALC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/15/2024	KeyCorp 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$103.00 ➝ $107.00	+10.08%
10/14/2024	BTIG Research 2 of 5 stars		Boost Target	Buy ➝ Buy	$104.00 ➝ $106.00	+9.40%
10/10/2024	Redburn Atlantic 0 of 5 stars	I. Kirby Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral
9/10/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Reynolds-Clar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Outperform
8/22/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$94.00 ➝ $105.00	+9.88%
8/22/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$103.00 ➝ $110.00	+16.25%
Get the Latest News and Ratings for ALC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.
8/22/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$104.00 ➝ $110.00	+16.25%
8/21/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$101.00 ➝ $101.00	+4.66%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underweight ➝ Equal Weight	$65.00 ➝ $85.00	-7.35%
5/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$95.00 ➝ $100.00	+12.02%
5/15/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $105.00	+17.62%
4/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.95%
3/4/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$90.00 ➝ $100.00	+16.31%
2/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$93.00 ➝ $96.60	+13.10%
11/20/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$94.00 ➝ $88.00	+23.40%
8/17/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$79.80 ➝ $89.30	+11.29%
3/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Hold
11/21/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		CHF 84 ➝ CHF 80
11/17/2022	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$67.00 ➝ $69.00	+4.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:43 PM ET.

Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 21, 2024. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

Here are some ways that investors could benefit from investing in Alcon Inc.:

Alcon Inc. has shown a positive Fifty-Two Week Performance of 11.11%.
Recent data indicates a Month-to-Month Change Percentage of 9.59%, suggesting potential growth.
With a low Short Percentage of Float at 0.87%, there is less short interest in the company.
Alcon Inc.'s Average Daily Volume is 815,800, indicating active trading in the stock.
The current Price on Record Date is $78.12, providing a snapshot of the stock's value.

Alcon
Bear Case

Investors should be bearish about investing in Alcon Inc. for these reasons:

The Institutional Ownership Percentage is 60.3%, which may lead to less volatility but also less potential for rapid price movements.
The Days to Cover ratio is 5.2, indicating a longer time for short sellers to cover their positions.
There has been a decrease in Shares Shorted from the previous month, which could indicate a lack of confidence in the stock.
Alcon Inc. has no Institutional Ownership Percentage, potentially signaling lower institutional support.
The Stock has a Short Percentage of Float at 0.87%, which may indicate some bearish sentiment in the market.

ALC Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $101.05, with a high forecast of $110.00 and a low forecast of $85.00.
: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALC shares.
: According to analysts, Alcon's stock has a predicted upside of 9.86% based on their 12-month stock forecasts.
: Over the previous 90 days, Alcon's stock had 2 upgrades by analysts.
: Alcon has been rated by research analysts at BTIG Research, KeyCorp, Needham & Company LLC, Oppenheimer, Redburn Atlantic, Robert W. Baird, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.
: Analysts like Alcon more than other "medical" companies. The consensus rating score for Alcon is 2.87 while the average consensus rating score for "medical" companies is 2.79. Learn more on how ALC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

This page (NYSE:ALC) was last updated on 10/31/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Stock Forecast & Price Target